Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostics Laboratory, |
RCV002237201 | SCV002507306 | pathogenic | Cockayne syndrome type 2 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003120845 | SCV003786504 | pathogenic | not provided | 2022-02-12 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with clinical features of Cockayne syndrome (PMID: 30842647). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu284*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). |